nonprofit logo

Fred Hutchinson Cancer Research Center

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 237156071 ✦ Seattle, WA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Fred Hutchinson Cancer Research Center?

Fred Hutchinson Cancer Research Center is a leading scientific research institute based in Seattle, Washington, with a workforce of approximately 3700 employees. Their mission is to drive discovery and make a positive impact on the world by pushing the boundaries of human knowledge in cancer and HIV research. The Vaccine and Infectious Disease Division (VIDD) at Fred Hutch integrates computational, laboratory, and clinical research methods to advance the understanding of microbial pathogenesis and infectious disease processes. Researchers at Fred Hutch collaborate with scientists from various laboratories, clinical sites, and field sites in the Americas, Africa, Asia, and Europe, focusing on infection-related cancers and diseases that affect high-risk populations in these regions. The division is actively engaged in initiatives in Uganda, China, and the Republic of South Africa. Their collaborative efforts aim to predict, detect, treat, and prevent infectious diseases in humans, including known and emerging infections of major global health importance, such as coronavirus and cancer-related infectious diseases.


Official website here: www.fredhutch.org/en.html

What are the reviews and ratings of this charity?

The Fred Hutchinson Cancer Research Center is not currently rated by Charity Navigator due to insufficient IRS Form 990 filings, which prevent evaluation through the typical Accountability & Finance methodology. While this lack of a rating does not imply any negative assessment, it means that certain financial and impact measurements cannot be analyzed or presented.

Despite the absence of a comprehensive rating, Fred Hutchinson Cancer Research Center demonstrates a strong commitment to equity, as highlighted by their high Equity Strategies score of 89 out of 100. The organization has implemented nine equity practices, with detailed descriptions available regarding their equity data and policies. Their Culture & Community score also stands at 89, reflecting positively on their social impact initiatives, although constituent feedback has not contributed to this score.

No user reviews are available on GreatNonprofits, so the public sentiment based on personal experiences with the organization is not documented here. Although specific evaluations like Leadership & Adaptability are not currently scored, the reported organizational practices underscore their commitment to racial equity and community culture.


This AI summary has been generated from information found on Charity Navigator.

Is Fred Hutchinson Cancer Research Center legitimate?

Fred Hutchinson Cancer Research Center is a legitimate nonprofit organization registered as a 501(c)(3) entity. Fred Hutchinson Cancer Research Center submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $15,334,946
Professional Fundraising Fees: $1,562,759
Other Salaries and Wages: $192,242,585

For more financial information, click here


Official website here: www.fredhutch.org/en.html

What is the mission statement of Fred Hutchinson Cancer Research Center?

The Fred Hutchinson Cancer Research Center is at the forefront of scientific research in cancer and HIV, pushing the boundaries of human knowledge. Their team of researchers are dedicated to leading the way towards a world free of cancer and related diseases through fearless science, collaboration, and unwavering focus. The center's Vaccine and Infectious Disease Division integrates the latest research methods to advance the understanding of microbial pathogenesis and infectious disease processes. Researchers collaborate with scientists worldwide to predict, detect, treat, and prevent infectious diseases in humans, including known and emerging infections of global health significance, such as coronavirus and cancer-related infectious diseases. Through their collaborative efforts, they strive to predict, detect, treat, and prevent infectious diseases in humans.


Official website here: www.fredhutch.org/en.html

Who is the CEO of Fred Hutchinson Cancer Research Center?

Dr Thomas Lynch Jr is the Principal Officer of Fred Hutchinson Cancer Research Center.


Official website here: www.fredhutch.org/en.html

What is the revenue of Fred Hutchinson Cancer Research Center?

Fred Hutchinson Cancer Research Center's revenue in 2022 was $696,845,474.


Official website here: www.fredhutch.org/en.html

Who are the executives of Fred Hutchinson Cancer Research Center and what are their salaries?

The average compensation at Fred Hutchinson Cancer Research Center during 2022 was $55,785. There are 3721 employees and 800 volunteers at Fred Hutchinson Cancer Research Center.


Here are 55 key members and their salaries:


Kathy Surace-Smith (Chair)
  • Compensation: $0
  • Related: $0
  • Other: $0
Leigh Morgan (Vice Chair)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sean Boyle (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Richard W Anderson (Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0
Carl Behnke (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael Clayville (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Hollis S Dillon (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mark Fleischauer (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Theresa Gillespie (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Stephen M Graham (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Christine Gregoire (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert Herbold (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Allan Jones (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Philip Kent (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Connie Kravas (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Matthew Mcilwain (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Norman Metcalfe (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Satya Nadella (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Paul W Reed (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Brian Roberts (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Corazon Sanders (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Pete Shimer (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Bryan White (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Thomas James Lynch Jr (President & Director)
  • Compensation: $1,702,109
  • Related: $0
  • Other: $66,608
Nancy E Davidson (Sr. Vp & Director, Crd)
  • Compensation: $1,266,466
  • Related: $0
  • Other: $47,218
Eric C Holland (Sr Vp & Dir, Human Biology)
  • Compensation: $776,770
  • Related: $0
  • Other: $53,518
David Harlan Browdy (Vp & Chief Financial Officer)
  • Compensation: $853,047
  • Related: $0
  • Other: $61,264
Bruce E Clurman (Exec Vp & Deputy Dir, Fhcrc)
  • Compensation: $767,846
  • Related: $0
  • Other: $56,974
Nicole C Robinson (Vp & Chief Operating Officer)
  • Compensation: $849,608
  • Related: $0
  • Other: $53,518
Frederick R Appelbaum (Exec Vp & Deputy Director)
  • Compensation: $758,585
  • Related: $0
  • Other: $55,623
Steven Haydon (Vp, General Counsel)
  • Compensation: $585,496
  • Related: $0
  • Other: $56,827
Geoffrey R Hill (Sr Vp & Dir Bgi)
  • Compensation: $450,843
  • Related: $0
  • Other: $55,890
Margaret Juliana Mcelrath (Sr Vp & Director - Vidd)
  • Compensation: $491,059
  • Related: $0
  • Other: $46,432
Kelly O'Brien (Vice President, Philanthropy)
  • Compensation: $515,402
  • Related: $0
  • Other: $56,339
Jodi Lorraine Burke (Vp Human Resources)
  • Compensation: $464,479
  • Related: $0
  • Other: $51,497
Marion S Dorer (Vp, Interdisciplinary Sci Adm)
  • Compensation: $478,101
  • Related: $0
  • Other: $47,124
Christopher Li (Vp, Faculty Affair & Diversity)
  • Compensation: $370,933
  • Related: $0
  • Other: $59,646
Garnet L Anderson (Sr Vp & Dir, Phs)
  • Compensation: $412,815
  • Related: $0
  • Other: $47,100
Jennifer E Griffith (Vp Gov'T & Community Relations)
  • Compensation: $368,396
  • Related: $0
  • Other: $46,834
Chris Bundesmann (Corporate Controller)
  • Compensation: $269,599
  • Related: $0
  • Other: $43,862
Jonathan A Cooper (Sr Vp & Dir, Basic Sciences)
  • Compensation: $262,229
  • Related: $0
  • Other: $43,876
Kathy L Alexion (Vp & Chief Information Officer)
  • Compensation: $321,053
  • Related: $0
  • Other: $35,200
Elizabeth Boyd (Vp, Res Adm & Faculty Affairs)
  • Compensation: $276,810
  • Related: $0
  • Other: $42,625
Paul M Buckley (Vp & Chief Divers/Incl Officer)
  • Compensation: $293,316
  • Related: $0
  • Other: $44,681
Herbert L Bone Iii (Corporate Treasurer)
  • Compensation: $231,853
  • Related: $0
  • Other: $44,129
Val Rie J Smith (Assistant To The Board Of Trustees)
  • Compensation: $117,182
  • Related: $0
  • Other: $18,078
Susan Biggins (Sr Vp & Dir, Basic Sciences)
  • Compensation: $112,819
  • Related: $0
  • Other: $0
Scott N Rusch (Vp, Facilities & Operations)
  • Compensation: $3,085
  • Related: $0
  • Other: $0
Kelly Patrick (Vp, Chief Information Officer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Steve Stadum (Spec Advisor)
  • Compensation: $1,132,208
  • Related: $0
  • Other: $56,974
Peter S Nelson (Full Professor)
  • Compensation: $449,036
  • Related: $0
  • Other: $60,222
Stephanie J Lee (Full Professor)
  • Compensation: $390,143
  • Related: $0
  • Other: $38,001
Jerald Patrick Radich (Full Professor)
  • Compensation: $396,440
  • Related: $0
  • Other: $59,736
Stanley R Riddell (Full Professor)
  • Compensation: $394,966
  • Related: $0
  • Other: $55,733
D Gary Gilliland (President & Director Emeritus)
  • Compensation: $168,188
  • Related: $0
  • Other: $0


Official website here: www.fredhutch.org/en.html

Where can I find the form 990 for Fred Hutchinson Cancer Research Center?

Fred Hutchinson Cancer Research Center's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.fredhutch.org/en.html

Learn more at the official website: www.fredhutch.org/en.html

Mission Statement of Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center (FRED HUTCH) is a pioneering institution in the realm of scientific research, primarily focusing on cancer and HIV. With a relentless pursuit of knowledge, its researchers are pushing the boundaries of human understanding, from fundamental biology to population-level health. Through fearless science, interdisciplinary collaboration, and unwavering focus, FRED HUTCH is spearheading the way towards a world devoid of cancer and related diseases.

The Vaccine and Infectious Disease Division (VIDD) at FRED HUTCH integrates cutting-edge computational, laboratory, and clinical research methods to advance the study of microbial pathogenesis and infectious disease processes. Researchers at VIDD collaborate with scientists from various disciplines and locations around the world, including the Americas, Africa, Asia, and Europe. The division boasts specific initiatives in Uganda, China, and the Republic of South Africa to expand the comprehension of infection-related cancers and infectious diseases that disproportionately affect high-risk populations in these regions. VIDD scientists, consisting of clinicians, clinical trial specialists, statisticians, computational biologists, and basic scientists, take pride in their collaborative efforts to predict, detect, treat, and prevent infectious diseases in humans. Their work encompasses well-known and emerging infections of significant global health importance, such as coronavirus, as well as cancer-related infectious diseases.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Fred Hutchinson Cancer Research Center is at the forefront of scientific exploration in cancer and HIV, driving discoveries that aim to improve global health. Its Vaccine and Infectious Disease Division (VIDD) employs advanced computational, laboratory, and clinical research techniques to deepen the understanding of microbial pathogenesis and infectious disease processes. VIDD collaborates with scientists across the Americas, Africa, Asia, and Europe, focusing on initiatives in Uganda, China, and the Republic of South Africa to study infection-related cancers and infectious diseases impacting high-risk populations.

The center's multidisciplinary teams, including clinicians, clinical trial specialists, statisticians, computational biologists, and basic scientists, are dedicated to predicting, detecting, treating, and preventing infectious diseases, particularly those with significant global health implications, such as coronaviruses and cancer-related infectious diseases. Through fearless scientific inquiry, interdisciplinary collaboration, and an unwavering commitment to innovation, Fred Hutch is pioneering efforts toward a world free of cancer and related diseases.




This information is meant to be a general summary of Fred Hutchinson Cancer Research Center. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$696,845,474 (2022)
Expenses
$610,254,707 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $89,242,611
  • Program Service Revenue: $56,158,707
  • Gross Receipts: $696,870,035

Assets and Liabilities:

  • Total Assets: $0
  • Total Liabilities: $0
  • Net Assets: $0

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

INTERAFFILIATE AGMTS

Revenue

$29,383,938

PATIENT SVCS AT SCCA

Revenue

$20,346,400

RESEARCH ACTIVITIES

Revenue

$8,855,036

SCCA INVESTMENT INCOME

Revenue

-$2,426,667

Organization Details

Founding Year

1971

Principal Officer

Dr Thomas Lynch Jr

Main Address

1100 FAIRVIEW AVENUE NORTH, SEATTLE, WA, 981091024

NTEE Category

Code: H300 - Medical research

If you are a representative of Fred Hutchinson Cancer Research Center and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.